| 1 | 000000000 | - | - | - | - | [1] 66 66 |
| 2 | A-623 or AMG 623 | - | - | - | - | [1] 66 66 |
| 3 | A07EA06 | - | - | - | - | [1] 66 66 |
| 4 | Abelmoschus manihot | - | - | - | - | [1] 66 66 |
| 5 | ACE inhibitor | - | - | - | - | [1] 66 66 |
| 6 | ACE inhibitor + statin | - | - | - | - | [1] 66 66 |
| 7 | ACE Inhibitor or Angiotensin receptor antagonist | [1] Angiotensin II Angiotensin II | [2] D00150
D00150
,
D02014
| [2] AGTR1 AGTR1, AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
| 8 | ACE/ARB | - | - | - | - | [1] 66 66 |
| 9 | ACEi | - | - | - | - | [2] 66 66, 224 |
| 10 | ACEI/ARB and corticosteroids | - | - | - | - | [1] 66 66 |
| 11 | Acteoside | [1] Acteoside Acteoside | - | - | - | [1] 66 66 |
| 12 | ACTH | [1] Corticotropin Corticotropin | [1] D00146
D00146
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [5] 13 13, 66, 145, 193, 222 |
| 13 | ACTH (Acthar) Gel | [1] Corticotropin Corticotropin | [1] D00146
D00146
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 66 66 |
| 14 | Acthar | [1] Corticotropin Corticotropin | [1] D00146
D00146
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [9] 2 2, 13, 14, 46, 49, 50, 66, 84, 222 |
| 15 | Acthar 80 unit injection | [1] Corticotropin Corticotropin | [1] D00146
D00146
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 66 66 |
| 16 | ActHIB | [1] Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | [2] 62 62, 66 |
| 17 | ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVERE+1 SIRINGA PRERIEMPITA SOLVENTE 0.5 ML | [1] Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | [2] 62 62, 66 |
| 18 | Aliskiren | [1] Aliskiren Aliskiren | [1] D03208
D03208
| [1] REN REN 💬 | [3] Diabetic cardiomyopathy Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [3] 66 66, 167, 222 |
| 19 | Allopurinol | [1] Allopurinol Allopurinol | [1] D00224
D00224
| [1] XDH XDH 💬 | [5] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | [6] 6 6, 46, 57, 66, 96, 97 |
| 20 | ALN-CC5 | - | - | - | - | [4] 11 11, 62, 66, 109 |
| 21 | ALXN1210 | - | - | - | - | [7] 2 2, 11, 13, 50, 62, 66, 109 |
| 22 | Angiotensin | [1] Angiotensin II Angiotensin II | [2] D00150
D00150
,
D02014
| [2] AGTR1 AGTR1, AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [7] 17 17, 19, 46, 66, 86, 222, 224 |
| 23 | Angiotensin blockade | [1] Angiotensin II Angiotensin II | [2] D00150
D00150
,
D02014
| [2] AGTR1 AGTR1, AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
| 24 | Angiotensin II | [1] Angiotensin II Angiotensin II | [2] D00150
D00150
,
D02014
| [2] AGTR1 AGTR1, AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 |
| 25 | APL-2 | - | - | - | - | [5] 2 2, 61, 62, 66, 222 |
| 26 | ARB | - | - | - | - | [1] 66 66 |
| 27 | ARO-C3 | - | - | - | - | [2] 62 62, 66 |
| 28 | Artesunate | [1] Artesunate Artesunate | [1] D02482
D02482
| - | - | [3] 18 18, 66, 96 |
| 29 | AT-1501 | - | - | - | - | [2] 2 2, 66 |
| 30 | Atacicept | [1] Atacicept Atacicept | [1] D09704
D09704
| [2] TNFSF13 TNFSF13, TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [4] 13 13, 46, 49, 66 |
| 31 | Atacicept 25 mg | [1] Atacicept Atacicept | [1] D09704
D09704
| [2] TNFSF13 TNFSF13, TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 13 13, 66 |
| 32 | Atacicept 75 mg | [1] Atacicept Atacicept | [1] D09704
D09704
| [2] TNFSF13 TNFSF13, TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 13 13, 49, 66 |
| 33 | Atacicept150mg | - | - | - | - | [1] 66 66 |
| 34 | Atacicept25mg | - | - | - | - | [1] 66 66 |
| 35 | Atacicept75mg | - | - | - | - | [1] 66 66 |
| 36 | ATG-F | - | - | - | - | [1] 66 66 |
| 37 | ATRASENTAN | [1] Atrasentan Atrasentan | - | - | - | [3] 66 66, 218, 222 |
| 38 | AVB-S6-500 | - | - | - | - | [1] 66 66 |
| 39 | Azathioprine | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [21] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 |
| 40 | Bardoxolone | [1] Bardoxolone Bardoxolone | [1] D09584
D09584
| - | - | [7] 66 66, 67, 84, 85, 86, 218, 222 |
| 41 | Bardoxolone methyl | [2] Bardoxolone Bardoxolone, Bardoxolone methyl | [2] D09584
D09584
,
D09585
| - | - | [7] 66 66, 67, 84, 85, 86, 218, 222 |
| 42 | Bardoxolone methyl capsules | [2] Bardoxolone Bardoxolone, Bardoxolone methyl | [2] D09584
D09584
,
D09585
| - | - | [4] 66 66, 67, 86, 222 |
| 43 | BCX9930 | - | - | - | - | [3] 62 62, 66, 222 |
| 44 | BCX9930 hydrochloride | - | - | - | - | [3] 62 62, 66, 222 |
| 45 | BELIMUMAB | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [12] 11 11, 13, 43, 44, 46, 49, 51, 53, 66, 222, 296, 300 |
| 46 | Benlysta | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [5] 43 43, 49, 53, 66, 222 |
| 47 | BENLYSTA® (belimumab) | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 11 11, 66, 222 |
| 48 | Bexsero | [1] Neisseria meningitidis serogroup b nhba fusion protein antigen Neisseria meningitidis serogroup b nhba fusion protein antigen | - | - | - | [6] 11 11, 13, 61, 62, 66, 222 |
| 49 | BEXSERO - SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - SIRINGA PRERIEMPITA (VETRO) - 0.5ML - 1 SIRINGA PRERIEMPITA CON AGO | [1] Neisseria meningitidis serogroup b nhba fusion protein antigen Neisseria meningitidis serogroup b nhba fusion protein antigen | - | - | - | [1] 66 66 |
| 50 | BION-1301 Multiple Doses | - | - | - | - | [1] 66 66 |
| 51 | BION-1301 Single Dose | - | - | - | - | [1] 66 66 |
| 52 | Blisibimod | [1] Blisibimod Blisibimod | [1] D10311
D10311
| - | - | [5] 43 43, 44, 49, 63, 66 |
| 53 | Blisibimod Injection | [1] Blisibimod Blisibimod | [1] D10311
D10311
| - | - | [1] 66 66 |
| 54 | Blood sample | - | - | - | - | [18] 8 8, 13, 46, 49, 51, 53, 61, 65, 66, 84, 96, 97, 107, 127, 235, 274, 288, 299 |
| 55 | BNJ441 | - | - | - | - | [1] 66 66 |
| 56 | BORTEZOMIB | [1] Bortezomib Bortezomib | [1] D03150
D03150
| [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [16] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 228, 256, 283, 288, 331 |
| 57 | Bortezomib (Velcade®) | [1] Bortezomib Bortezomib | [1] D03150
D03150
| [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 66 66 |
| 58 | BUDESONIDE | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9] 66 66, 93, 94, 95, 96, 97, 98, 228, 299 |
| 59 | C09 | - | - | - | - | [1] 66 66 |
| 60 | Calcitriol | [1] Calcitriol Calcitriol | [1] D00129
D00129
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [9] 18 18, 37, 46, 49, 66, 96, 158, 235, 326 |
| 61 | CCX168 | - | - | - | - | [5] 43 43, 44, 66, 109, 222 |
| 62 | Cemdisiran | [1] Cemdisiran Cemdisiran | - | - | - | [4] 11 11, 62, 66, 109 |
| 63 | Chinese Herb Prescription Granule plus prednisone | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 64 | Cilazapril | [1] Cilazapril Cilazapril | [2] D01069
D01069
,
D07699
| [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 66 66 |
| 65 | Corticosteroid | - | - | - | - | [10] 13 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 |
| 66 | Corticotherapy | - | - | - | - | [1] 66 66 |
| 67 | Cyclophosphamid | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [1] 66 66 |
| 68 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [45] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 |
| 69 | Decortin H | - | - | - | - | [3] 66 66, 97, 145 |
| 70 | Dihuang | [1] Rehmannia glutinosa root Rehmannia glutinosa root | - | - | - | [3] 46 46, 66, 76 |
| 71 | Dipyridamole | [1] Dipyridamole Dipyridamole | [1] D00302
D00302
| [2] PDE4A PDE4A, PDE5A 💬 | [6] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [6] 46 46, 49, 51, 66, 96, 224 |
| 72 | Enalapril | [1] Enalapril Enalapril | [2] D00621
D00621
,
D07892
| [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [6] 19 19, 46, 66, 113, 210, 222 |
| 73 | ENALAPRIL VALSARTAN METHYLPREDNISONE | [3] Enalapril Enalapril, Methylprednisone, Valsartan | [3] D00400
D00400
,
D00621
,
D07892
| [2] ACE ACE, AGTR1 💬 | [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
| 74 | Fecal microbiota transplantation | - | - | - | - | [5] 2 2, 66, 94, 96, 97 |
| 75 | Felzartamab | [1] Felzartamab Felzartamab | - | - | - | [1] 66 66 |
| 76 | Fish Oil | [1] Fish oil Fish oil | - | - | - | [7] 13 13, 46, 49, 66, 96, 260, 299 |
| 77 | FOS | - | - | - | - | [2] 66 66, 96 |
| 78 | Fostamatinib | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [4] 46 46, 49, 61, 66 |
| 79 | Fostamatinib 100 mg | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 |
| 80 | Fostamatinib 100 mg tablet | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 |
| 81 | Fostamatinib 150 mg | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 |
| 82 | Fostamatinib 150 mg tablet | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 |
| 83 | Fostamatinib Disodium | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [3] 46 46, 61, 66 |
| 84 | Fostamatinib Disodium tablet 100 mg | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 |
| 85 | Fostamatinib Disodium tablet 150 mg | [1] Fostamatinib Fostamatinib | [1] D09347
D09347
| [1] SYK SYK 💬 | [17] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1] 66 66 |
| 86 | Gastrus | - | - | - | - | [1] 66 66 |
| 87 | GSK1550188 | - | - | - | - | [4] 11 11, 49, 66, 222 |
| 88 | HAEMOPHILUS INFLUENZAE | - | - | - | - | [3] 61 61, 62, 66 |
| 89 | Hiberix | [1] Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | [4] 13 13, 61, 62, 66 |
| 90 | HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML | [1] Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | [3] 61 61, 62, 66 |
| 91 | High Dose-VIS649 | - | - | - | - | [1] 66 66 |
| 92 | Hormone (prednisone) | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 93 | HR19042 capsule | - | - | - | - | [1] 66 66 |
| 94 | HR19042 Capsules | - | - | - | - | [1] 66 66 |
| 95 | Human soluble recombinant Fc-gamma receptor IIB | - | - | - | - | [1] 66 66 |
| 96 | Hydroxychloroquine | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
| - | - | [27] 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
| 97 | HYDROXYCHLOROQUINE SULFATE | [2] Hydroxychloroquine Hydroxychloroquine, Sulfate ion | [1] D08050
D08050
| - | - | [3] 46 46, 53, 66 |
| 98 | Immunosuppressants | - | - | - | - | [1] 66 66 |
| 99 | Immunosuppressive treatment | - | - | - | - | [1] 66 66 |
| 100 | Infusion of ADR-001 (Mesenchymal stem cell) | - | - | - | - | [1] 66 66 |
| 101 | Inhibace/Cozaar | - | - | - | - | [1] 66 66 |
| 102 | Intervention for incipient patients at low risk of disease progression | - | - | - | - | [1] 66 66 |
| 103 | Intervention for patients at high risk of disease progression | - | - | - | - | [1] 66 66 |
| 104 | Intravenous Rituximab | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 66 66 |
| 105 | IONIS-FB-LRx | - | - | - | - | [1] 66 66 |
| 106 | Iptacopan | [1] Iptacopan Iptacopan | [1] D12251
D12251
| [1] CFB CFB 💬 | [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [5] 61 61, 62, 66, 109, 222 |
| 107 | IRBESARTAN | [1] Irbesartan Irbesartan | [1] D00523
D00523
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [4] 66 66, 167, 168, 222 |
| 108 | Irbesartan tablets | [1] Irbesartan Irbesartan | [1] D00523
D00523
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 |
| 109 | Irbesartan tablets (ANDA 203071) | [1] Irbesartan Irbesartan | [1] D00523
D00523
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
| 110 | Irbesartan tablets (Approved in the USA. Reference listed drug Avapro) NDC # 43547-0374-03 | [1] Irbesartan Irbesartan | [1] D00523
D00523
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 |
| 111 | Irbesartan tablets (NDA 020 757) | [1] Irbesartan Irbesartan | [1] D00523
D00523
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
| 112 | Leflunomide | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [12] 11 11, 40, 46, 49, 53, 66, 107, 162, 224, 270, 271, 300 |
| 113 | Leflunomide 20 mg+prednisone 0.5mg/kg/d | [2] Leflunomide Leflunomide, Prednisone | [2] D00473
D00473
,
D00749
| [2] DHODH DHODH, NR3C1 💬 | [4] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬 | [1] 66 66 |
| 114 | Lisinopril | [1] Lisinopril Lisinopril | [2] D00362
D00362
,
D08131
| [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [7] 19 19, 46, 49, 66, 67, 113, 222 |
| 115 | LNP023 | - | - | - | - | [5] 61 61, 62, 66, 109, 222 |
| 116 | Losartan | [1] Losartan Losartan | [2] D00357
D00357
,
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [18] 17 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| 117 | Low antigen content diet | - | - | - | - | [1] 66 66 |
| 118 | Low Dose-VIS649 | - | - | - | - | [1] 66 66 |
| 119 | MASP-2 antibody | [1] Narsoplimab Narsoplimab | [1] D11531
D11531
| [1] MASP2 MASP2 💬 | [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [3] 64 64, 66, 109 |
| 120 | MASP-2 Antibody, OMS00620646, OMS620646 | [1] Narsoplimab Narsoplimab | [1] D11531
D11531
| [1] MASP2 MASP2 💬 | [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [1] 66 66 |
| 121 | Medium Dose-VIS649 | - | - | - | - | [1] 66 66 |
| 122 | Menatetrenone | [1] Menatetrenone Menatetrenone | [1] D00100
D00100
| - | - | [1] 66 66 |
| 123 | Menveo | [1] Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine | - | - | - | [6] 11 11, 13, 61, 62, 66, 222 |
| 124 | MENVEO - POLV.E SOLUZ.PER SOLUZ. INIETT.-USO INTRAMUSCOLARE-COMP. CONIUG.LIOFILIZZ.MENA:FLAC.(VETRO) COMP. GONIUG.LIQUI.MENCWY:FLAC.(VETRO)-1 FLAC+1FLAC | [1] Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine | - | - | - | [2] 62 62, 66 |
| 125 | Methylprednisolon | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [4] 13 13, 14, 51, 66 |
| 126 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
| 127 | Methylprednisolone (MP) or prednisone (pred) | [2] Methylprednisolone Methylprednisolone, Prednisone | [7] D00407
D00407
,
D00473
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 128 | METHYLPREDNISOLONE MYLAN Générique | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 129 | Methylprednisolone pulse | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 220 |
| 130 | Methylprednisolone(intravenously in the 1st-2nd-3rd month ) | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 131 | Methylprednisolone(intravenously in the 1st-3rd-5th month) | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 132 | Methylprednisone | [1] Methylprednisone Methylprednisone | - | - | - | [3] 46 46, 66, 222 |
| 133 | Mezagitamab | [1] Mezagitamab Mezagitamab | [1] D11945
D11945
| [1] CD38 CD38 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 66 66 |
| 134 | Mizoribine | [1] Mizoribine Mizoribine | [1] D01392
D01392
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [8] 46 46, 49, 51, 53, 66, 94, 222, 224 |
| 135 | MMF | - | - | - | - | [15] 13 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 162, 222, 224, 226, 299 |
| 136 | MOR03087 | - | - | - | - | [2] 66 66, 222 |
| 137 | MOR202 | - | - | - | - | [2] 66 66, 222 |
| 138 | Multi-glycoside of Tripterygium Wilfordii HOOK. f. (TWH) | [1] Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | [1] 66 66 |
| 139 | Mycophenolat-Natrium | - | - | - | - | [1] 66 66 |
| 140 | Mycophenolate | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [36] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
| 141 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] D00752
D00752
,
D05094
,
D05095
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [34] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
| 142 | Mycophenolate mofetil (MMF) | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] D00752
D00752
,
D05094
,
D05095
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [7] 13 13, 49, 51, 60, 65, 66, 222 |
| 143 | Mycophenolate mofetil plus lower dose of Prednisone | [3] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid, Prednisone | [5] D00473
D00473
,
D00752
,
D05094
,
D05095
,
D05096
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [1] 66 66 |
| 144 | Mycophenolate sodium | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [3] 53 53, 66, 222 |
| 145 | Mycophenolic acid | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [8] 11 11, 43, 49, 51, 60, 66, 96, 222 |
| 146 | Mycophenolic sodium | - | - | - | - | [2] 66 66, 222 |
| 147 | Myfortic | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [5] 49 49, 66, 162, 222, 228 |
| 148 | Myfortic 180mg Tablets | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [2] 66 66, 222 |
| 149 | Myfortic 360mg Tablets | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [2] 66 66, 222 |
| 150 | Narsoplimab | [1] Narsoplimab Narsoplimab | [1] D11531
D11531
| [1] MASP2 MASP2 💬 | [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [2] 66 66, 222 |
| 151 | NEFECON | - | - | - | - | [1] 66 66 |
| 152 | Omega-3 | [1] Omega-3 fatty acids Omega-3 fatty acids | - | - | - | [7] 13 13, 46, 49, 66, 79, 96, 299 |
| 153 | Omega-3 fatty acid | [1] Omega-3 fatty acids Omega-3 fatty acids | - | - | - | [2] 46 46, 66 |
| 154 | Omega-3 fatty acid ethylester90 | [1] Omega-3 fatty acids Omega-3 fatty acids | - | - | - | [1] 66 66 |
| 155 | Omega-3 Fatty Acid Fish Oil Supplement | [2] Fish oil Fish oil, Omega-3 fatty acids | - | - | - | [1] 66 66 |
| 156 | OMS721 | - | - | - | - | [3] 64 64, 66, 109 |
| 157 | OMS721 (narsoplimab) | [1] Narsoplimab Narsoplimab | [1] D11531
D11531
| [1] MASP2 MASP2 💬 | [3] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | [2] 66 66, 222 |
| 158 | OPL-CCL2-LPM | - | - | - | - | [1] 66 66 |
| 159 | Other: continue their usual therapy | - | - | - | - | [1] 66 66 |
| 160 | Other: intensive supportive care | - | - | - | - | [1] 66 66 |
| 161 | Other: Optimized Supportive Care | - | - | - | - | [1] 66 66 |
| 162 | Other: Vehicle (D5W or saline) | - | - | - | - | [1] 66 66 |
| 163 | Over-encapsulated 150 mg Irbesartan Tablets | [1] Irbesartan Irbesartan | [1] D00523
D00523
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
| 164 | Over-encapsulated Irbesartan | [1] Irbesartan Irbesartan | [1] D00523
D00523
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 |
| 165 | Over-encapsulated Irbesartan Tablets | [1] Irbesartan Irbesartan | [1] D00523
D00523
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 222 |
| 166 | Paricalcitol | [1] Paricalcitol Paricalcitol | [1] D00930
D00930
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [4] 19 19, 66, 218, 238 |
| 167 | Placebo | - | - | - | - | [27] 3 3, 5, 6, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 |
| 168 | Plasma exchange (PE) | - | - | - | - | [3] 64 64, 66, 220 |
| 169 | PNEUMOVAX – Soluzione iniettabile in siringa preriempita da 0,5 ml | - | - | - | - | [2] 62 62, 66 |
| 170 | Potassium | [1] Potassium Potassium | [1] D08403
D08403
| - | - | [12] 36 36, 46, 66, 67, 88, 94, 98, 115, 167, 179, 215, 235 |
| 171 | Prednisolon | - | - | - | - | [7] 46 46, 50, 51, 66, 95, 96, 97 |
| 172 | PREDNISOLONE | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [43] 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
| 173 | Prednisone | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
| 174 | Prednisone + Inhibace/Cozaar | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 175 | Prednisone 5 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 66 |
| 176 | Prednisone alone | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 11 11, 66 |
| 177 | Prednisone and cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Prednisone | [3] D00287
D00287
,
D00473
,
D07760
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 178 | PREDNISONE ARROW 20mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 179 | PREDNISONE ARROW 5 mg | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 180 | Prednisone in full dose | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 181 | Prednisone or Prednisolone | [2] Prednisolone Prednisolone, Prednisone | [9] D00472
D00472
,
D00473
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 84 |
| 182 | Prednisone plus cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Prednisone | [3] D00287
D00287
,
D00473
,
D07760
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 183 | Probucol | [1] Probucol Probucol | [1] D00476
D00476
| - | - | [1] 66 66 |
| 184 | ProTectis | - | - | - | - | [1] 66 66 |
| 185 | R935788 | - | - | - | - | [3] 46 46, 61, 66 |
| 186 | Ramipril | [1] Ramipril Ramipril | [1] D00421
D00421
| [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [7] 46 46, 49, 66, 67, 113, 218, 257 |
| 187 | Rapamune | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [8] 2 2, 60, 66, 67, 84, 158, 278, 280 |
| 188 | RAS | - | - | - | - | [4] 6 6, 13, 58, 66 |
| 189 | RAS 2410 | - | - | - | - | [1] 66 66 |
| 190 | RAVULIZUMAB | [1] Ravulizumab Ravulizumab | [1] D11054
D11054
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [7] 2 2, 11, 13, 50, 62, 66, 109 |
| 191 | RC18 160mg | - | - | - | - | [3] 11 11, 13, 66 |
| 192 | RC18 240mg | - | - | - | - | [2] 13 13, 66 |
| 193 | RE-021 | - | - | - | - | [3] 66 66, 218, 222 |
| 194 | Reh-acteoside | [1] Acteoside Acteoside | - | - | - | [1] 66 66 |
| 195 | Renin Angiotensin system (RAS) blockade | [1] Angiotensin II Angiotensin II | [2] D00150
D00150
,
D02014
| [2] AGTR1 AGTR1, AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
| 196 | Risedronate | [1] Risedronic acid Risedronic acid | [3] D00942
D00942
,
D03234
,
D08484
| [1] FDPS FDPS 💬 | [4] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [7] 46 46, 50, 66, 96, 107, 113, 274 |
| 197 | Rituximab | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [49] 6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
| 198 | Simulect | [1] Basiliximab Basiliximab | [1] D03058
D03058
| [1] IL2RA IL2RA 💬 | [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 66 66, 97 |
| 199 | Simvastatin | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [21] 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
| 200 | Sirolimus | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [36] 6 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 |
| 201 | Sirolimus (study drug)+ACE inhibitor + statin | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 66 66 |
| 202 | SM101 | - | - | - | - | [3] 49 49, 63, 66 |
| 203 | Smofkabiven | [1] Sodium glycerophosphate Sodium glycerophosphate | [1] D10489
D10489
| - | - | [1] 66 66 |
| 204 | SMOFKABIVEN - EMULSIONE PER INFUSIONE SENZA ELETTROLITI 1 SACCA BIOFINE MULTICOMPARTIMENTATE DA 493 ML | [1] Sodium glycerophosphate Sodium glycerophosphate | [1] D10489
D10489
| - | - | [1] 66 66 |
| 205 | SPARSENTAN | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 66 66, 218, 222 |
| 206 | Sparsentan compresse | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
| 207 | Sparsentan tablets | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
| 208 | Sparsentan tablets/ Over-encapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
| 209 | Sparsentan tablets/Over-encapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
| 210 | Sparsentan tablets/over-encapsulated Spasenten tablets | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
| 211 | Sparsentan tablets/Overencapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
| 212 | Stasis | [1] Ferric sulfate Ferric sulfate | [1] D08922
D08922
| - | - | [2] 66 66, 97 |
| 213 | Steroids | - | - | - | - | [7] 46 46, 50, 51, 63, 66, 96, 97 |
| 214 | Steroids plus azathioprine | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [1] 66 66 |
| 215 | Sulfate | [1] Sulfate ion Sulfate ion | - | - | - | [27] 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 218, 222, 226, 265, 296, 297, 299 |
| 216 | Supportive and immunosuppressive therapy | - | - | - | - | [1] 66 66 |
| 217 | Supportive therapy | - | - | - | - | [1] 66 66 |
| 218 | Supportive therapy with: ACE-inhibitor / ARB / Statin | - | - | - | - | [1] 66 66 |
| 219 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] D00107
D00107
,
D08556
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
| 220 | Tailored diet | - | - | - | - | [1] 66 66 |
| 221 | Telitacicept 160mg | - | - | - | - | [1] 66 66 |
| 222 | Telitacicept 240mg | - | - | - | - | [1] 66 66 |
| 223 | Telmisartan | [1] Telmisartan Telmisartan | [1] D00627
D00627
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 66 66, 67 |
| 224 | The Yi-Qi-Qing-Jie herbal compound | - | - | - | - | [1] 66 66 |
| 225 | Tripterygium | [1] Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | [8] 46 46, 66, 67, 96, 162, 222, 224, 271 |
| 226 | Tripterygium Wilfordii | [1] Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | [6] 46 46, 66, 67, 222, 224, 271 |
| 227 | Tripterygium wilfordii (TW) | [1] Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | [2] 66 66, 222 |
| 228 | Ultomiris | [1] Ravulizumab Ravulizumab | [1] D11054
D11054
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [6] 2 2, 11, 13, 50, 62, 66 |
| 229 | VACCINO CONTRO IL MEMINGOCOCCO DI GRUPPO B | - | - | - | - | [3] 61 61, 62, 66 |
| 230 | VACCINO PNEUMOCOCCICO | - | - | - | - | [2] 62 62, 66 |
| 231 | VACCINO POLISACCARIDICO ANTI-MENINGOCOCCICO (A.C.Y E W-135) | - | - | - | - | [3] 61 61, 62, 66 |
| 232 | Valsartan | [1] Valsartan Valsartan | [1] D00400
D00400
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [7] 57 57, 58, 66, 75, 218, 222, 224 |
| 233 | VIS649 | - | - | - | - | [1] 66 66 |
| 234 | VT-001 | - | - | - | - | [1] 66 66 |
| 235 | Warfarin | [1] Warfarin Warfarin | [3] D00564
D00564
,
D01280
,
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [13] 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
| 236 | WM (Shentong Granules) | - | - | - | - | [1] 66 66 |
| 237 | LNP023 HYDROCHLORIDE SALT | - | - | - | - | [5] 61 61, 62, 66, 109, 222 |